Clinical Study
Vitamin D Supplementation Improves Mood in Women with Type 2 Diabetes
Table 1
Baseline enrollment characteristics.
| | Eligible () | Not eligible () | | Mean (SD) | Mean (SD) |
| Demographics | | | | Mean age (SD) | 54.32 (10.64) | 51.54 (9.09) | 0.205 | Years with diabetes (SD) | 7.85 (7.00) | 6.94 (5.18) | 0.526 | Race/ethnicity (Col%) | | | 0.428 | White | 58% | 63% | | Black | 38% | 28% | | Hispanic | 4% | 9% | | | () | () | | Mood outcomes | | | | Depression—CES-D | 26.84 (7.70) | 30.77 (11.32) | 0.066 | Depression—PHQ-9 | 11.50 (5.33) | 14.77 (6.22) | 0.014 | State anxiety | 42.42 (11.06) | 45.65 (13.82) | 0.250 | Trait anxiety | 49.24 (8.21) | 52.4 (11.95) | 0.167 | Health status | | | | Mental SF-12 | 35.30 (9.21) | 35.65 (9.93) | 0.871 | Physical SF-12 | 45.56 (11.02) | 42.93 (8.16) | 0.254 | Laboratory measures | | | | 25-Hydroxyvitamin D (ng/ml) | 19.18 (7.22) | 21.03 (10.62) | 0.396 | HbA1c (%) | 6.87 (0.80) | 7.87 (1.75) | 0.004 | Weight (pounds) | 227.65 (57.22) | 226.21 (59.30) | 0.914 |
|
|
Note: independent t-tests and Fischer’s exact test were used to compare group differences at baseline.
|